This study will test the hypothesis that a novel combination of three drugs (sorafenib, sonidegib, and irinotecan), in conjunction with individually optimized doses, can be safely administered and lead to improved clinical outcomes in patients with…
- Investigator
- Ali Zarrinpar
- Status
- Accepting Candidates
- Ages
- 18 Years - 99 Years
- Sexes
- All